abstract |
Use of compounds of the formula (I) in which R 1 , R 4 , R 2 , R 4 and R 5 are as defined in claim 1, and physiologically acceptable salts and solvates thereof, for the treatment of obesity, sub-types of anxiety, sub-types of schizophrenia and types of dementia of various origin. |